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A B S T R A C T
Positively charged halloysite nanotubes functionalized with triazolium salts (f-HNT) were employed as a
carrier for curcumin molecules delivery. The synthesis of these f-HNT new materials is described. Their
interaction with curcumin was evaluated by means dynamic light scattering (DLS) and UV–vis
spectroscopy in comparison with pristine unmodiﬁed HNT (p-HNT). The curcumin load into HNT was
estimated by thermogravimetric analysis (TGA) measurements, while the morphology was investigated
by scanning electron microscopy (SEM) techniques. Release of curcumin from f-HNT, at three different pH
values, by means of UV–vis spectroscopy was also studied. Furthermore, different cancer cell lines were
used to evaluate the potential cytotoxic effect of HNT at different concentrations and culture times. The
results indicated that the f-HNT drug carrier system improves the solubility of curcumin in water, and
that the drug-loaded f-HNT exerted cytotoxic effects against different cell lines.
ã 2014 Elsevier B.V. All rights reserved.
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Phenolic compounds originated from one of the main class of
secondary metabolites in plants, are natural phytochemicals
mostly deriving from phenylalanine, which are widely present
in food and nutraceuticals (Aggarwal et al., 2008). Among them,
curcumin and its derivatives have been extensively studied and
evaluated for their biological activity.
Curcumin [bis(4-hydroxy-3-methoxy-phenyl)-1,6-heptadiene-
3,5-dione] is a natural phenolic compound isolated as a yellow
pigment from the dried rhizome of Curcuma longa, a plant that is
widely cultivated in tropical areas of Asia and Central America,
commonly used as a spice, as a food colorant, and even as a food
preservative. Several studies, also, report that it is an agent
possessing a wide variety of biological and pharmacological
activities, including anti-proliferation (Choi et al., 2006), anti-* Corresponding author. Tel.: +39 9123897546; fax: +39 091596825.
** Corresponding author. Tel.: +39 9123897962.
E-mail addresses: serena.riela@unipa.it (S. Riela), giuseppe.lazzara@unipa.it
(G. Lazzara).
http://dx.doi.org/10.1016/j.ijpharm.2014.09.019
0378-5173/ã 2014 Elsevier B.V. All rights reserved.apoptosis (Aggarwal et al., 2008), anti-angiogenesis (Lin et al., 2007)
and inhibition of cell invasion and metastasis (Chen et al., 2008).
Successful application of this compound is hampered, however,
by the occurrence of some disadvantageous properties. Being
hydrophobic in nature, curcumin is sparingly soluble in water
(ca. 0.6 mg/mL). Moreover, it degrades rapidly under neutral or
alkaline conditions, with a half-life shorter than 10 min in
phosphate buffer solution at pH 7.2 (Kurien et al., 2007). As a
result, its bioavailability is poor, particularly after oral or topical
administration (Anand et al., 2007). Therefore, a carefully designed
carrier could signiﬁcantly facilitate curcumin delivery and broaden
the range of its possible pharmaceutical applications.
Nanoscale drug delivery systems are an innovative approach for
overcoming the aforementioned problems. Previous attempts at
encapsulating curcumin in liposomes, phospholipid complexes, or
other nanoparticle-based technologies have been reported, show-
ing an improvement in water dispersibility and a longer circulation
time (Tang et al., 2010; Duan et al., 2010; Kim et al., 2011)
A possible nanosized delivery system is constituted by naturally
available clay halloysite nanotubes (HNT). Halloysite has been
found a viable and inexpensive nanoscale container for the
encapsulation of biologically active molecules such as biocides
and drugs, as Price et al. (2001) ﬁrst demonstrated.
614 S. Riela et al. / International Journal of Pharmaceutics 475 (2014) 613–623Halloysite is a hydrated polymorph of kaolinite consisting of
silica on the outer surface and alumina at the innermost surface of
the tubular structure (Bates et al., 1950). Therefore, the different
inner and outer-compositions of these materials allow to accom-
plish different chemical reactions on either surface (Massaro et al.,
2014a,b; Li et al., 2008; Du et al., 2010; Wang et al., 2008; Vergaro
et al., 2010; Lvov et al., 2002; Matsuno et al., 2003, 2006; Ma et al.,
2011, 2012; Terayama et al., 2010; Horiuchi et al., 2009).
The functionalization of HNT with organic salts is a good
strategy to prepare a new class of materials presenting most of the
features and properties of organic salt, allowing them to be
dispersed in physiological media.
For the cellular internalization of nanoparticles in general,
surface charge is, also, important in determining whether the
nanoparticles would cluster in blood ﬂow or would adhere to, or
interact with oppositely charged cells membrane (Feng, 2004). A
cationic surface is desirable as it promotes the interaction between
the nanoparticles and the cells, and hence increases the rate and
extent of internalization (Shenoy and Amiji, 2005).
In the last years triazolium derivatives have attracted the
attention of scientists because the N-alkyl-1,2,3-triazoles moiety is
easily accessible through the versatile copper-catalyzed (CuAAC)
[2 + 3] cycloaddition (Huisgen, 1963; Meldal and Tornoe 2008; Finn
and Fokin, 2010).
Triazoles and their derivatives, indeed, occupy a central position
(Noël et al., 2009) amongst the most signiﬁcant compounds that
constitute pharmaceutically and medicinally important drug
centers (Al-Masoudi et al., 2006). Several triazoles have been
reported to possess antibacterial (Singh et al., 2006), antifungal
(Rezaei et al., 2009), antitumor (Guo-Qiang et al., 2008), plant
growth regulating (Jin et al., 2007) and cytotoxic (Bagihalli et al.,
2008) activities.
In this work we report the selective functionalization of
halloysite nanotubes at the external surface with triazolium salts
and the interaction of these nanomaterials with curcumin. The
functionalization served for two purposes: (i) introducing a
positive charge on the halloysite carrier; (ii) verifying whether
the presence of the biological active triazolium moiety could exert
a synergic effect with curcumin.Scheme 1. Synthesis of fun2. Experimental
2.1. Materials and methods
All reagents and materials needed were used as purchased
(Aldrich), without further puriﬁcation.
Halloysite was supplied by Applied Minerals. This material has
an average tube diameter of 50 nm and inner lumen diameter of
15 nm. Typical speciﬁc surface area of this halloysite is 65 m2/g;
pore volume of 1.25 mL/g; refractive index 1.54; and speciﬁc
gravity 2.53 g/cm3.
The 3-azidopropyltrimethoxysilane was synthetized as previ-
ously reported (Karl and Buder, 1983).
UV–vis spectra were recorded on a Beckmann DU 650 spec-
trometer.
IR spectra were recorded with an Agilent Technologies Cary
630 FTIR spectrometer. Specimens for measurements were
prepared by mixing 5 mg of the sample powder with 100 mg of
KBr.
An ESEM FEI QUANTA 200 F microscope was used to study the
morphology of the functionalized HNTs. Before each experiment,
the sample was coated with gold under argon by means of an
Edwards Sputter Coater S150A to avoid charging under the electron
beam.
Thermogravimetric analyses were performed on a Q5000 IR
apparatus (TA Instruments) under a nitrogen ﬂow (25 cm3min1
for the sample and 10 cm3min1 for the balance). The weight of
each sample was ca. 10 mg. The measurements were carried out by
heating the sample from room temperature up to 900 C at a rate of
10 C min1. The difference between the thermoanalytical curve of
loaded HNT or f-HNT and the corresponding pristine nanoparticles
was calculated, in order to highlight the degradation of the
curcumin present in the composites.
The DLS measurements were performed at 22.0  0.1 C in a
sealed cylindrical scattering cell at a scattering angle of 90, by
means of a Brookhaven Instrument apparatus composed of an
BI-9000ATcorrelator and a He–Ne laser (75 mW) at a wavelength
(l) of 632.8 nm. The solvent was ﬁltered by means of a Millipore
ﬁlter with 0.45 mm pore size. For all systems, the ﬁeld-timectionalized f-HNT3a-b.
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exponential decay function, which provides the decay rate (G )
of the single diffusive mode. For the translational motion, the
collective diffusion coefﬁcient at a given concentration is Dt = G /q2
where q is the scattering vector given by 4pnl1sin(u/2) where n is
the water refractive index and u is the scattering angle.
Turbidimetric measurements were performed with a Beck-
mann DU 650 spectrometer.
z-potential measurements were performed by means of a
ZETASIZER NANO ZS90 (Malvern Instruments).
The dispersions were sonicated with an ultrasound bath VWR
Ultrasonic Cleaner (power 200 W, frequency 75 MHz).
2.2. Syntheses
2.2.1. Synthesis of compound 1
In a typical synthetic run, 100 mL of 3-azidopropyl trimethox-
ysilane was dissolved in 20 mL of dry toluene and 1 g of clay
powder was added. The suspension was ﬁrst dispersed under
ultrasonic irradiation for 15 min, and then reﬂuxed for 16 h under
stirring. Afterwards, the crude solid ﬁltered off, washed with
several aliquots of MeOH and dried overnight at 80 C under
vacuum.
Whitish powder: 0.95 g.
IR (KBr): n = 2103 (s, ns N3).
TGA: loss peak of 1.5% at a temperature of 254 C.
2.2.2. General synthesis of compound 2
Compound 1 (500 mg) was suspended in a H2O/t-BuOH 1:1
mixture (4 mL) t and propargyl alcohol (20.7 mg, 10 eq) was added.
The mixture was stirred under argon in the presence of catalytic
amount of CuSO4/sodium ascorbate solution (1 M, 1:10 v/v) at
room temperature for 24 h. After this time, the solvent was ﬁltered
off, the powder was rinsed with H2O, then with MeOH and ﬁnally
dried at 80 C under vacuum.0
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Fig. 1. Diffusion coefﬁcient obtained by DLS measurements for 3b as a funcIR(KBr): n = 2937 (w), 2885(w, s, ns CH2); 1641(s, ns CQN), 1400
(w, ns NQN), 1324 (w, ns CN).
TGA: weight loss of 2.3% in a range between 222 and 380 C.
2.2.3. General procedure for the synthesis of compounds 3a-b
Compound 2 (100 mg) was suspended in dry toluene (10 mL)
and an excess of the proper iodoalkane was added. The suspension
was then reﬂuxed at 120 C for 24 h. After this time, the solid was
ﬁltered off, rinsed with CH2Cl2 and ﬁnally dried at 80 C under
vacuum.
3a: TGA: weight loss of 5.9% at temperature of 344 C.
IR (KBr): n = 2951 (w, n CQC), 2927 (m), 2857(w, ns CH2), 1630
(s, ns CQN), 1460 (w, ns NQN), 1320 (s, ns CN).
3b: TGA: weight loss of 8.5% at temperature of 475 C.
IR (KBr): n = 2961 (w, n CQC), 2949 (m), 2876 (w, ns CH2), 1626
(s, ns CQN), 1462 (w, ns NQN), 1320 (s, ns CN).
2.3. General procedure to obtain HNT/curcumin dispersions
Varying weighed amounts of p-HNT (from 1.2 up to 18 mg) or
f-HNT3a-b (from 0.1 up to 0.9 mg) were dispersed by sonication for
5 min in the proper solvent, at an ultrasound power of 200 W and a
temperature of 25 C. 1 mL of curcumin solution in the solvent was
added to the HNT dispersions. The ﬁnal volume was 10 mL and
2 mL for p-HNT and f-HNT3a-b dispersions, respectively. Final
curcumin concentration was 1 104M.
2.4. Loading procedure
2.4.1. p-HNT
In order to encapsulate the curcumin inside the halloysite
nanotubes, we mixed 20 mg of halloysite, as dry powder, with few
milliliters of saturated solution of curcumin in ethanol. The
suspension was sonicated for 5 min, at an ultrasound power of
200 W and a temperature of 25 C and then was evacuated for1008060
 w/w Methanol
tion of different percent of methanol in methanol/water mixed media.
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under vacuum.
2.4.2. f-HNT3a-b
To a dispersion of f-HNT3a-b in a water/methanol 9:1 (250 mL)
mixture 2.5 mL of a curcumin solution 102M in methanol were
added. The obtained dispersion was stirred for 48 h at r.t. and then
ﬁltered off, washed with small amounts of water and ﬁnally dried
at 60 C under vacuum overnight.
2.5. Release kinetics
The release kinetics at 37 C were evaluated in HCl 0.1 N, in
phthalate buffer solution pH 5 or in phosphate buffer pH 8. UV–vis
measurements were carried out by suspending 5 mg of HNT/Curc
in 3 mL of the chosen solvent buffer. In all cases sink conditions
were maintained.
2.6. Efﬁciency of curcumin loaded-halloysite and f-HNT3a.
The human papillary thyroid carcinoma cell line BCPAP and the
human anaplastic thyroid carcinoma cell lines SW1736, 8505 C and
C643 were kindly provided by Prof. F Frasca, University of Catania,
Italy. BCPAP and 8505c were cultured in RPMI 1640 (PAA),
supplemented with 10% FBS, 5% penicillin–streptomycin, and 5%
glutamine. SW1736 and C643 cell line was cultured in DMEM
(PAA), supplemented with 10% FBS, 5% penicillin–streptomycin,
and 5% glutamine cultures were maintained in 5% CO2 at 37 C in a
humidiﬁed incubator.
HA22T/VGH, HepG2 and Hep3B is a poorly differentiated
hepatoma cell line which contains HBV integrants. It was cultured
in Roswell Park Memorial Institute (RPMI) 1640 (HyClone Europe
Ltd., Cramlington UK) supplemented with 10% heat-inactivated
fetal calf serum, 2 mM L-glutamine, 1 mM sodium pyruvate,
100 units/ml penicillin and 100 mg/ml streptomycin (all reagents
were from HyClone Europe) in a humidiﬁed atmosphere at 37 C inFig. 2. Trend of the absorbance of the curcumin (1 104M) as function of p-HNT c
(lmax = 360 nm); (b) H2O/MeOH 9:1 (lmax = 425 nm). The inset shows a representation 5% CO2. Cells having a narrow range of passage number were used
for all experiments.
2.7. Cell growth assays
2.7.1. MTS assay
In order to test the effects of the agents, the cells were seeded at
2  104 cells/well onto 96-well plates and then incubated
overnight. At time 0, the medium was replaced with fresh
complete medium and thereof curcumin, HNT/Curc or f-HNT
3a/Curc, were added according to the concentrations indicated
later. At the end of treatment, 16 mL of a commercial solution
(Promega Corporation, Madison, WI, USA) containing 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxy methoxyphenyl)-2-(4-sul-
phophenyl)-2H-tetrazolium (MTS) and phenazine ethosulfate
were added. The plates were incubated for 2 h in a humidiﬁed
atmosphere at 37 C under 5% CO2. The bioreduction of the MTS dye
was assessed by measuring the absorbance of each well at 490 nm.
Cytotoxicity was expressed as a percentage of the absorbance
measured in the control cells.
2.7.2. MTT assay
Cell proliferation was assessed by colorimetric assay using
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT). Cells were plated in 96-well plate at a density of
5 103cells/well and cultured up to 24, 48 and 72 h in the presence
of HNT/Curc or f-HNT 3a/Curc. At the end of the incubation period
the cells were incubated for 4 h at 37 C with MTT; then the
medium was removed and the cells were treated with DMSO for
5 min. Absorbance was read at 550 nm in a Multiskan FC
microplate reader (Thermo Fisher Scientiﬁc).
Protocol to determine the amount of curcumin embedded into
cells.
The amount of drug embedded into cells (Ccell) was determined
by the following equation:oncentration (from 0 to 1.8  103 g/mL) in (a) buffer solution, pH 8/MeOH 9:1
cartoon of hypothesized equilibria.
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where Ci is the concentration of curcumin associated to halloysite
and Cf is the drug concentration in supernatant after incubation,
respectively. The curcumin content in the supernatant was
determined spectrophotometrically at 445 nm referring to a
standard calibration curve.
3. Results and discussion
3.1. Synthesis and properties of functionalized halloysite nanotubes
The HNT-bearing random triazolium salts, f-HNT3a-b, were
prepared according to the synthetic route shown in Scheme 1.
Starting with halloysite nanotubes treated with an excess of
3-azido-propyl trimethoxysilane, the compound 1 was prepared.
After work-up the azido groups loading, estimated by TGA, was as
large as 1.5%. The introduction of the triazole moiety, on the
external surface of 1 by the CuAAC reaction, gave compound 2,
which was puriﬁed by repeated washing with water and methanol.
Finally, compounds 3a-b were prepared by dispersing 2 in toluene
under ultrasound irradation, followed by addition of proper alkyl
iodide.
FTIR investigation on 1, 2, 3 shows that the vibrational bands of
HNT remain unchanged after the reactions (data are reported in SI).
The frequency and assignments of each vibrational mode are based
on previous halloysite reports (Yuan et al., 2008; Tonle et al., 2003;
Vansant et al., 1995; White and Tripp, 2000; Madejova and
Komadel, 2001; Vranken et al., 1992). Compared to p-HNT, 1
exhibits the CH2 asymmetric and symmetric stretching at
2930 cm1 and 2850 cm1 respectively, the CH2 scissoring at
1470 cm1 and the stretching of the azido groups at 2103 cm1. In
the 2 and 3a-b compounds, the stretching of the aromatic HCQ,
CQN, NQN, CN groups around 3000, 1600, 1400 and
1320 cm1 respectively are also observed. These ﬁndings evidence
the presence of the silane moieties in 1 and triazolic groups in 2
and 3 and, based on the unaltered frequency of stretching bands ofFig. 3. Trend of the absorbance (lmax = 440 nm) of the curcumin (1 104M) as function o
shows a representation cartoon of hypothesized equilibria.the OH of the inner-surface Al-OH groups, led to conclude that
grafting has taken place only on the external surface of HNT.
The samples 3a-b were investigated by means of TGA to
determine the grafted amount of organic moieties (Fig. S.6 in SI).
Three steps of mass loss were observed for 3a-b. By comparison
with the thermoanalytical curve for p-HNT, which presents two
dehydration steps at ca. 500 and 700 C, the 3a-b show also a mass
loss in the range from 200 to 400 C accounting for the degradation
and volatilization of the organic fractions. The grafting degree was
determined by comparing the residual masses at 900 C of each
f-HNT and p-HNT; results as large as 6.1 wt% and 8.6 wt% were
obtained for 3a and 3b respectively. The difference in the grafting
degree is, of course, due to the different molecular weight of the
grafted organic moieties.
Direct observation of the surface morphology of 3a and 3b was
accomplished by SEM (see SI). In both cases the tubular shape of
the nanoclay is not lost after grafting. Moreover, the lumen of the
functionalized nanotubes appears empty, in agreement with the
expected grafting at the external surface. The characteristic
average size of the functionalized nanotubes are coincident with
those observed for the p-HNT (Cavallaro et al., 2011).
3.2. Colloidal stability of f-HNT.
Turbidimetric analyses were performed to highlight the
inﬂuence of functionalization on the dispersion stability of
f-HNT in aqueous media, which might be crucial for possible
application as drug carrier.
A dispersion of f-HNT3a showed a higher stability in water than
3b, according to the more hydrophobic surface functionalization in
3b as compared to 3a (data are shown in Fig. S.9 of SI). These data
can be interpreted under the light of the diffusion coefﬁcient of the
nanoparticles in the solvent. With the aim of using these new
systems as drug carriers, we studied the stability of dispersions in
an organic solvent such as methanol able to solubilize curcumin in
larger amounts. The diffusion coefﬁcients of 3a and 3b obtained by
DLS experiments are respectively (1.18  0.02)  1012 andf (a) 3a, (b) 3b concentration (from 0 to 1.8  103 g/mL) in H2O/MeOH 9:1. The inset
Fig. 4. SEM images for (a) 3a/Curc; (b) 3b/Curc; (c) p-HNT/Curc.
Fig. 5. Thermoanalytical curves of f-HNT3a/Curc (—) and f-HNT3b/Curc (—). The
thermoanalytical curves were subtracted to f-HNT3a-b to show degradation peaks
of curcumin.
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(1.54  0.11)  1012m2 s1 in methanol.
By comparing these results with the diffusion coefﬁcient of
p-HNT in water (9.4 1013m2 s1) (Cavallaro et al., 2011) it
appears that in methanol both 3a and 3b form no aggregates. This
is not the case in water where the more hydrophobic substituent
plays a role favoring the aggregation of nanotubes, as evidenced by
the slower diffusion for 3b. This result can be explained
considering that water is a worse solvent for the most hydrophobic
external modiﬁer. The reduced diffusion dynamic was obtained for
p-HNT by hydrophobic modiﬁcation of the outer surface by means
of a cationic surfactant (Cavallaro et al., 2012) and the nanotubes
aggregation due to hydrophobic lateral interaction was claimed in
that case. With the aim at evidencing possible changes in the
nanoparticle–nanoparticle interactions, the z-potential in water
was measured. Both samples 3a-b showed close negative
z-potential values (19.5 1.5 and 24.1 0.9 mV, respectively)
and therefore differences in the electrostatic nanoparticle–
nanoparticle repulsions are probably negligible, conﬁrming that
the aggregation of compounds is driven by p–p and van der Waals
interactions.
Based on our results, we planned to investigate the colloidal
stability of 3b in methanol/water mixed media. To this purpose
diffusion coefﬁcients were measured in a wide range of solvent
compositions (Fig. 1). It is straightforward to note that 3b is rather
stable in the methanol rich regime, as it is proved by a value of the
diffusion coefﬁcient close to the one expected for monodispersed
nanotubes. On the other hand, if the methanol concentration is
lower than 8.4% (corresponding to 9:1 water/methanol volume
ratio), diffusion is suddenly slowed down. In principle this effect
can be due to: (i) change in the viscosity of the solvent medium;
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interactions between the external moieties.
To the light of the monotonic change of methanol/water
mixture (Thompson et al., 2006), the aggregation occurs in our
system.
3.3. Interactions between HNT and curcumin
The incorporation of curcumin in HNT formed a stable, strongly
colored dispersion. Color indicates a homogeneous distribution of
curcumin in the aqueous medium.
The interaction between p-HNT or 3a-b compounds with
curcumin was evaluated by DLS measurements and Uv–vis
spectroscopy.
In order to highlight the interactions of 3a-b with curcumin the
diffusion dynamic of the modiﬁed nanotubes was studied as a
function of the curcumin concentration in the mixed methanol/
water solvent. The volume ratio water/methanol was ﬁxed at
9:1 which is the best compromise between curcumin solubility
and the stability of f-HNT dispersions (Fig. 1). The concentration
dependence of the diffusion coefﬁcient was negligible (see data in
SI) and therefore average values of (3.0  1.0)  1013m2 s1 and
(6.0  3.0)  1013m2 s1 were calculated for 3a and 3b, respec-
tively. These results show a signiﬁcant slowdown of both f-HNT
nanoparticles in the presence of curcumin, indicating that the
interaction favors the aggregation or networking of the nanotubes.
Considering the results obtained from DLS measurements,
mentioned above, we recorded the UV–vis spectra of dispersion
of p-HNT/curcumin (p-HNT/Curc) both in buffer pH 8 solution/
methanol 9:1 mixture (lmax = 360 nm) and a water/methanol 9:1
mixture (lmax = 425 nm), at 25 C and at a ﬁxed concentration of
curcumin (1 104M) in the presence of increasing amounts of
p-HNT (0–1.8  103 g/mL). The occurrence of the interaction was
evaluated by measuring the absorbance at the maximum absorp-
tion wavelength of the curcumin in each mixed solvent. Typical
trends are depicted in Fig. 2.
Two different behaviors were observed depending on the
medium solvent used. In the buffer solution/methanol mixture
(Fig. 2a) absorbances (recorded at 360 nm) decrease on increasing
of p-HNT concentration. Moreover, after interaction with p-HNT,
the p-HNT/Curc has a peak at the same absorption wavelength as
free curcumin. These ﬁndings suggest that curcumin has beenb)a
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Fig. 6. Amount of curcumin released from (a) 3b as a function of tsuccessfully encapsulated into the HNT lumen. Similar results are
reported in literature for the encapsulation of curcumin within
poly(amidoamine) dendrimers (Wang et al., 2013).
In the neutral H2O/MeOH 9:1 mixture two absorbance maxima,
at 260 and 425 nm were observed. The absorbance values at
425 nm decrease on increasing the amounts of p-HNT. By contrast,
absorbances at 260 nm increase up to a p-HNT concentration of ca.
6  103 g/mL, and then reach a plateau at larger concentrations
(Fig. 2b). These trends could indicate that two different equilibria
occur in solution, i.e. the loading of curcumin into the lumen of
p-HNT and its adsorption onto p-HNT external surface.
Similarly, we recorded the UV–vis spectra of f-HNT3a-b/Curc in
mixed water/methanol 9:1 solvent, at 25 C and a ﬁxed concen-
tration of curcumin (1 104M) in the presence of varying
amounts of compounds 3a-b (0–9  104 g/mL). According to the
previous observations, also in this case we remarked two different
behaviors.
We observed an initial decrease of the absorbance value and
then an increase on increasing the f-HNT concentration (Fig. 3a). As
previously mentioned, we have hypothesized the coexistence of
two different “curcumin species”, one encapsulated and the other
adsorbed onto external surface, of f-HNT. The initial decrease could
be due to the encapsulation of curcumin in the 3a lumen, whereas
the subsequent increase in the absorbances may be attributed to
the formation of an adsorbed complex. The introduction of a
positive charge onto the external surface of f-HNT makes the
curcumin being preferentially adsorbed onto the external surface,
by means of more effective p–p and cation–p interactions.
Unfortunately, in the latter case we could not obtain any data for
the absorbance value at 260 nm because of the concomitant
occurrence of the absorption band of the triazolium moieties
present onto the f-HNT surface.
Fig. 3b shows the variation in the absorbance of curcumin as a
function of 3b concentration. In this case, we have supposed that
the external functionalization, which has longer side alkyl chain
length, contributes more to the adsorption of curcumin on the
external surface.
3.3.1. Loading procedure
Loading HNT/Curc was made with two different procedures,
depending on the p-HNT or f-HNT used. According to literature
(Veerabadran et al., 2007) we performed a loading procedure from)
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Fig. 7. MTS test for cell viability of HA22T/VGH, SW1736 and BCPAP cells cultured
for 72 h in presence of free curcumin, 3a, p-HNT/Curc and 3a/Curc.
Fig. 8. Graphical representation of curcumin amount (mol) into the cells as a
function of initial amount of curcumin (mol) for HA22T/VGH cell line.
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solubility for the drug.
Loading of the p-HNT with curcumin was based on vacuum
cycling of a halloysite suspension in a saturated solution
containing curcumin, as described previously (Price et al., 2001;
Abdullayev et al., 2009). This cycle was repeated several times in
order to get the highest loading efﬁciency. After loading, the
p-HNT/Curc complex was washed in order to remove any curcumin
not interacting with p-HNT. Differently for f-HNT/Curc loading, the
nanotubes (0.2 mg/mL) were left under constant stirring at room
temperature in mixed water/methanol 9:1 solvent with curcumin
at a concentration as larger as 105M.
In both cases subsequent investigations were conducted on the
dry solid ﬁltered from dispersion, washed with water and dried
overnight at 60 C.
The obtained materials are imaged by SEM (Fig. 4) and it turned
out that in the submicron range the typical tubular shape is
preserved in all cases, whereas f-HNT and p-HNT loaded with
curcumin showed a very different morphology in a larger length
scale. In particular f-HNT/Curc did not show any peculiar
organization while p-HNT/Curc presented a ﬁber-like structure.
Each ﬁber was ca. 8 mm large in diameter and several millimeters
long. Moreover, the presence of HNT within the ﬁber with the
nanoparticles distributed without an apparent orientation is
observed (Fig. 4c).
TGA experiments endowed to estimate the amount of curcumin
in the solid materials.
This was determined by comparing the residual mass at 400 C
of each sample, and resulted to be as large as 1.5, 11.0 and 12.5% for
p-HNT, 3a and 3b respectively. Besides the high loading obtained, it
is very interesting to observe from TGA data that the degradation
temperature of the organic moieties is dependent on the
investigated system. In particular, the curcumin encapsulated in
p-HNT shows a higher degradation temperature (536 C) as
compared to the pure compound (323 C). This striking enhance-
ment of the thermal stability can be due to encapsulation of the
degradation products into the nanotube lumen (Cavallaro et al.,
2011; Du et al., 2006). It is intriguing to notice that loaded f-HNT3a-
b showed two differential degradation peaks for curcumin(401 and 320 C for 3a; 570 and 320 C for 3b), which can be
attributed to the molecules at the outer surface and incorporated
into the cavity (Fig. 5). By comparing the data for loaded HNT and
f-HNT one can assume that incorporated curcumin is present in the
f-HNT and that the more hydrophobic modiﬁcation generates a
preferential interaction of the curcumin with the outer surface. The
latter ﬁndings are in agreement with the UV–vis results.
3.4. Release kinetics
Controlled release is an attainable and desirable characteristic
for a drug carrier. The factors affecting the drug release rate rely on
the structure of the matrix where the drug is contained and the
chemical properties associated with both the clay and the drug.
The drug release is also diffusion controlled as the drug can travel
through the pore of halloysite. The most desirable release proﬁle
would show a constant release rate with time (Vergaro et al., 2010).
pH is a key factor inﬂuencing the oral drug delivery. It is known
that pH is about 1.2–2.0 in stomach, about 7.0 in small intestine and
as high as 8 in the distal part (Shargel and Yu, 2012).
In Fig. 6 extended release proﬁle of curcumin from f-HNT and
p-HNT is elucidated.
The release of curcumin at pH 1 from compound 3b reaches a
plateau after 150 min, an initial burst is observed within 100 min
followed by a prolonged release. The obtained result is outstanding
because it is well known that curcumin suffers from chemical
instability in the gastrointestinal tract.
Release proﬁles obtained at pH 5 and pH 8 showed in both cases
only a small amount of curcumin released from the systems. The
same conclusions can be drawn for compound 3a (see SI).
As it can be seen there are signiﬁcant difference for the release
in different pH conditions, which can be explained as follows. A
ﬁrst factor to keep into account is the different solubility as a
function of pH. Indeed curcumin molecules (pKa1 = 8.38,
pKa2 = 9.88 and pKa3 = 10.51) can exist as cationic, neutral or
anionic species in acidic, neutral or alkaline solution, respectively
(Bernabé-Pineda et al., 2004). Therefore, curcumin can be easily
migrated out of the carrier at pH 1 in its cationic form, resulting in a
higher release as compared with that at pH 5.0 and 8.0.
The interaction of curcumin and f-HNT is another reason for the
difference in drug release behavior. In acidic solution both f-HNT
and curcumin are positively charged; therefore, electrostatic
repulsions may also accelerate the release of drug from the
f-HNT3b.
In the case of p-HNT (Fig. 6b), the release of curcumin at pH
1 showed a similar behavior than the release, at the same pH, from
f-HNT.
Release of curcumin from HNT can be considered the phase of
desorption of the previously adsorbed drug molecules from a
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solid/liquid interface process will be involved different simple
interface processes leading to the transport of the drug from the
solid to the liquid phase. These simple processes may be governed
by diffusion and in our particular case are due to the desorption of
the drug adsorbed on the external HNT surface.
To better understand the release mechanism of curcumin from
the different carriers, we analyzed the experimental data obtained
for f-HNT/3b with the following equations: ﬁrst-order (2) and the
Power law (3):
Ft ¼ 1  ekt (2)
Ft ¼ ktn (3)
where Ft is the drug release fraction at time t, k is the release
constant of the respective equations, t is the release time and n is
the characteristic diffusion exponent.
The correlation coefﬁcient for Eq. (2), either for the release from
p-HNT and f-HNT, is higher than the Power ﬁt equation, so the
release mode of curcumin, in both cases, follows the ﬁrst-order
kinetics.
3.5. Cells viability
In order to validate the efﬁciency of p-HNT/Curc and f-HNT
3a/Curc on cell viability we tested a panel of 7 tumor cell lines,
namely 8505C, BCPAP, C643, SW1736, HA22T/VGH, Hep3B and
HepG2. We performed MTT and MTS tests in order to verify if the
complexes are able to exert antitumoral action.
Cell viability was estimated at 24, 48 and 72 h under different
curcumin concentrations (in the 1–100 mM range). It was observed
that cell viability decreases in a concentration and time dependent
way. The inhibition efﬁciency of the complex increased when the
incubation time was prolonged from 24 to 72 h, the f-HNT 3a/Curc
displayed signiﬁcantly stronger anticancer activity than free
curcumin.
In Fig. 7 data regarding the antitumor effects of curcumin and
its derivatives on the cell lines of hepatocarcinoma HA22T/VGH,
anaplastic thyroid SW1736 and papillary thyroid BCPAP after 72 h
of incubation are shown; the results obtained from treatment with
f-HNT3a are reported for useful comparison.
The survival rates of the various tumor cells incubated with
p-HNT at each concentration were found in the range of 96–100%,
indicating they have no effect on cell viability of the tumor cell
lines under the concentration conditions investigated. This result is
not surprising because it is well known that HNT materials have no
cytotoxic effects (Lai et al., 2013) whereas f-HNT3a, as it can be
noticed from Fig. 7, exerts variable cytotoxic effects against the
different cell lines with IC50 of 40.0  14.6 mM. This different
behavior could be due to the introduction of triazolium salts onto
the carrier, that it is known to possess very interesting biological
activities, in particular antitumoral effect (Pokhodylo et al., 2013).
It is known that nanoparticles enter cells through an internali-
zation mechanism that presumably involves an endocytosis
process, whereby f-HNT3a could be uptake into the cytosol by
endosomes (Zhang et al., 2009).
Free curcumin has no effect on cell viability, probably due to its
rapid metabolism and systemic elimination, which limits its
clinical application (Anand et al., 2007).
No cytotoxic effects for the several cell lines in the presence of
the complex p-HNT/Curc were observed. In our opinion the
availability of curcumin encapsulated in the halloysite lumen is
low, so it is not released in these conditions. Similar results were
obtained by Leporatti et al. for resveratrol (Vergaro et al., 2010).The f-HNT 3a/Curc shows, at each concentration, a signiﬁcantly
higher cytotoxicity than free curcumin. In particular, the concen-
tration of f-HNT3a/Curc which caused 50% inhibition of cell growth
was 11.0  6.4 mM for HA22T/VGH, 23.0  8.6 mM for SW1736 and
23.1 10.6 mM for BCPAP respectively. This increase in the
cytotoxicity of f-HNT3a/Curc compared with free curcumin was
probably due to the possibility of enhanced cellular uptake via
endocytic process combined with enhanced aqueous solubility of
f-HNT3a/Curc.
The increase in the cytotoxicity of f-HNT3a/Curc with respect to
p-HNT/Curc can be explained as follows: (i) f-HNT3a/Curc has the
largest curcumin loading; (ii) in the case of f-HNT3a is inside and
outside the nanotubes, and therefore the drug can be released
quickly from the carrier.
Fig. 8 shows the amount of curcumin that is embedded in the
HA22T/VGH cells after treatment with free curcumin, p-HNT/Curc
and f-HNT3a/Curc.
Despite free curcumin enters almost totally in the cells, it has no
effect on cell viability probably because it is rapidly degraded as a
consequence of its instability in the culture medium (Wang et al.,
2008).
On the contrary, when cells were treated with 3a/Curc, we
observe that curcumin enters in the cells until the concentration
reaches the IC50 value. This may indicate that it is necessary a low
amount of drug to exert a therapeutic activity.
Based on the cytotoxicity assays, we summarized the IC50
values for f-HNT3a/Curc against each cell lines after an incubation
time of 72 h. It was found that the complex is active against several
tumor cell lines (data are shown in Table S.1 in Supporting
information).
It is noteworthy that f-HNT 3a/Curc is extremely effective
toward both differentiated and undifferentiated tumor cell lines.
This observation results particularly important on considering
that at present there is no antitumoral chemiotherapic drug
against anaplastic thyroid cancer (ATC) and survival of patients is
less than 1 year. Moreover for resistant cell lines, such as the
hepatic cancer HA22T/VGH cell, curcumin was usually adminis-
tered in combination with other chemiotherapic agents to achieve
synergistic antitumor effect (Notarbartolo et al., 2005; Ganta and
Amiji, 2009).
4. Conclusions
We have successful modiﬁed the external surface of halloysite
with triazolium salts.
The new materials obtained were characterized by means of
FTIR spectroscopy, TGA, SEM and z-potential measurements that
conﬁrm the presence of triazolium moiety. With the aim to employ
them as carrier for curcumin, we tested their aqueous stability by
turbidimetric analysis and DLS measurements. The interaction
with the potential drug was evaluated by DLS and UV–vis
spectroscopy. The results obtained conﬁrmed the coexistence of
different “curcumin species” depending on the system considered;
one encapsulated and one adsorbed onto halloysite. Release
kinetics showed that the new systems have a different release
proﬁles depending on pH of the medium.
These systems have the advantage of high drug encapsulation
efﬁciency, as well as controlled and sustained release capabilities;
moreover, the triazole moiety, into the HNT surface, was found to
have a synergic effect with curcumin, which make f-HNT an ideal
carrier for anti-cancer therapies as conﬁrmed by MTT and MTS
assays.
Assays performed on a large panel of cancer cell lines to valuate
cytotoxic effects of curcumin and its derivatives, showed that the
complex f-HNT 3a/Curc is active in several tumor models.
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